CME: Family Planning with MS: Case Perspectives

Family Planning with MS: Case Perspectives

Family Planning with MS: Case Perspectives

The debate surrounding how to manage MS patients during the childbearing years is becoming increasingly common. So what’s the right approach?

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Recently released data and publications have started to change the discussion on family planning for patients with MS. And to help put those recommendations into action, this activity will review a case commonly seen by neurologists as well as women’s health professionals, while offering new perspectives and opportunities for this unique patient group.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Jiwon Oh, MD
    Staff Neurologist
    St. Michael’s Hospital/University of Toronto
    Toronto, Ontario

    Dr. Oh has disclosed she receives consulting fees from Biogen-Idec, EMD-Serono, Novartis, Roche, and Sanofi and she also receives research support from Biogen-Idec, and Roche.

    Maria K. Houtchens, MD
    Associate Professor of Neurology
    Harvard University
    Boston, MA

    Dr. Houtchens has disclosed she receives consulting fees from Biogen, Roche, Sanofi, and Teva and she also receives research support from Biogen, and Serono.

    Reviewers/Content Planners/Authors:
    • Sean T. Barrett has nothing to disclose.
    • Rob Braun has nothing to disclose.
    • Ann Early has nothing to disclose.
    • Barry A. Fiedel, PhD has nothing to disclose.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Discuss the misconceptions about family planning associated with a diagnosis of MS
    • Describe the typical natural course of relapses during pregnancy and postpartum and how relapses are managed during pregnancy
  • Target Audience

    This activity is designed to meet the educational needs of Neurologists, Primary Care and Ob/Gyn physicians, nurses, nurse practitioners, physician assistants, and other members of the interprofessional team who are involved in the management of patients with multiple sclerosis.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 CreditsTM to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMECs) should contact the UEMS at

  • Provider(s)/Educational Partner(s)

    AGILE - Academy for Interprofessional Learning and Education - designs, develops, and delivers education across a broad spectrum of diseases and clinical conditions.  Our mission is to serve as a trusted source of clinical information that helps healthcare professionals improve competence, performance, and patient outcomes

  • Commercial Support

    This educational activity is supported by an independent grant from the Healthcare business of Merck KGaA, Darmstadt, Germany.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and AGILE. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of AGILE you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

    Disclaimer: Some products discussed in this activity may not have received regulatory approval by the US FDA for the treatment of patients. The FDA has stated that “good medical practice and the best interests of the patient require that physicians use legally available drugs, biologics and devices according to their best knowledge and judgement”.

Facebook Comments


We’re glad to see you’re enjoying Global Women's Health Academy…
but how about a more personalized experience?

Register for free